Advanced Chemotherapies Technologies, Inc. is a privately owned, clinical-stage company developing novel approaches to local drug delivery such as their innovative drug delivery solution, ACT-IOP-003, a potential treatment for borderline resectable and non-resectable pancreatic cancer.
Adwanted Group provides multiple technology platforms for use in the advertising industry including software to media buyers or sellers, data, and training to help them navigate with efficiency in a constantly evolving environment.
Aegle Therapeutics is a clinical-stage regenerative medicine company that is developing a first in class therapy using extracellular vesicles, including exosomes, secreted by allogeneic bone marrow derived mesenchymal stem cells to treat severe dermatological conditions including dystrophic epidermolysis bullosa, a rare pediatric blistering disease.
Afresh sells software that tracks demand and manages orders for fresh produce in grocery stores. The company aims to reduce food waste and increase access to nutritious food.
Agora is a technology company offering a Real-Time Engagement Platform-as-a-Service, or RTE-PaaS. The platform provides software developers simple-to-use, highly customizable and widely compatible application programming interfaces, or APIs, to embed real-time video and voice functionalities into their applications without the need to develop the technology or build the underlying infrastructure themselves.
Agora Systems is a digital purchasing platform that allows contractors to streamline the materials purchasing and management process. Their software brings field, office, warehouse, and vendors onto one collaborative platform.
Air Protein is a startup that has leveraged ideas from NASA to develop a novel technology that can make “meat” out of air. The Air Protein Flour is a sustainable and complete protein and is a proposed solution to the population growth and food demand growth expected over the next 30 years.
Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss.
Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. They have developed proprietary platforms to generate tumor targeting agents with ideal properties for radiotherapy maximizing tumor elimination while minimizing side effects of treatment.
Alignment Healthcare is a patient-centric healthcare company that connects senior citizens with on-demand healthcare in a variety of settings. Alignment values personalized care, lowest cost of care, and a VIP member experience.
Aligos Therapeutics develops pharmacologically optimized drug candidates, which are first assessed in healthy volunteers and patients as monotherapy prior to their use in combination regimens designed to achieve improved treatment outcomes in patients. Their team focuses on viral and liver diseases and leverages their in-depth knowledge and expertise to develop combination regimens for each disease area with significant unmet medical need.
Allonnia uses advanced biology and progressive technology to unlock the potential in waste. They design and deploy at-scale innovations in water and wastewater treatment, soil redemption, and solid waste management and upcycling.
AlloVir is a late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases.
This article does not constitute legal or tax advice. Please consult with your legal or tax advisor with respect to your particular circumstance.